MoneyWorks4Me

Zydus Lifesciences informs about press release

17 May 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated May 17, 2024 titled ‘Zydus and MSN announces exclusive licensing and supply agreement for Cabozantinib Tablets (generic version of CABOMETYX®) for the US market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1741.60
Dr. Reddys Labs. 1239.90
Cipla 1327.80
Lupin 1944.90
Zydus Lifesciences 1118.60
View more..